11 January 2007
Tullett Prebon plc
Completion of the acquisition of
Chapdelaine Corporate Securities & Co
The Board of Tullett Prebon plc announces that the Company has completed the
acquisition of 100 per cent. of the stock of Chapdelaine Corporate Brokers Inc.
and 100 per cent. of the membership interests of C&W Corporate Securities LLC,
these two entities being the owners of Chapdelaine Corporate Securities & Co.
('CCS').
As announced by the Company on 27 October in a statement advising that Heads of
Agreement had been signed with the principal shareholders, the consideration
remains $95 million payable in cash, $57 million of which is payable on
completion and the balance over the next 3 years, part of which is dependent on
CCS' performance.
CCS is a long-established New York business which provides brokerage services
in corporate bonds, credit derivatives, mortgage backed securities and
equities. For the twelve months ended 30 June 2006 CCS reported audited
revenues of $118m.
The acquisition will deepen and strengthen Tullett Prebon's capabilities in
North America, particularly in Credit products.
- Ends -
Enquiries:
Nigel Szembel, Head of Communications mobile: +44 7802 362088
Tullett Prebon plc
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.